Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility

NCT05332639 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05332639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05332639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
October 3, 2025
Completion date
November 30, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn colitis, crohn disease, crohn's duodenitis, crohn's esophagitis, crohn's gastritis, crohn's ileocolitis, crohn's jejunitis, inflammatory bowel diseases